Brazil OK's Medical Marijuana, Denies Cannabis Cultivation
On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products (1). However, it denied a proposal that would allow domestic medical marijuana plantations. According to Anvisa, the new regulations will be published in Brazil’s official gazette in the next few days; 90 days later, they will come into law. The regulatory body also set out specific rules for the manufacture, import, sale, packaging, marketing, and regulation of the new class of cannabis-based products.
This is a major step, given the country’s amount of drug-related violence. But Brazil still trails Uruguay and Colombia in regard to cultivation. In 2013, Uruguay legalized the growing, selling, and smoking of marijuana. Colombia followed suit shortly after, being the second Latin American country to legalize medicinal marijuana.
Anvisa said that cannabis-based products will only be available for sale in registered pharmacies, and with a prescription.
Read the full report on Reuters.
References:
Global Survey Examines Cannabis Use over Pharmaceuticals for Endometriosis Symptom Relief
June 17th 2025A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.
Best of the Week: June 6 – June 12, 2025
June 13th 2025Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.
